Chemically Synthesized H3K14Ub Unveils Clr4's IDR‐Mediated Multivalent Nucleosome Recognition in H3K9 Methylation
Abstract
ABSTRACT Histone H3 lysine 9 methylation (H3K9me) is a central epigenetic mark governing heterochromatin formation. Although the H3K9 methyltransferase Clr4 has been extensively characterized using short histone peptide substrates, how it recognizes and coordinates different structural domains to engage physiological substrate nucleosomes remains poorly understood. Here, we employed chemical protein synthesis to generate site‐specifically ubiquitinated H3K14Ub histones and nucleosomes, enabling quantitative biochemical and structural investigations. Using a CAET handle‐assisted strategy, we obtained homogeneous H3K14Ub nucleosomes and demonstrated that ubiquitination enhances Clr4 activity by ∼350‐fold on nucleosomes relative to unmodified substrates. Clr4 domain deletion analyses revealed that, the intrinsically disordered region (IDR) of Clr4 is critical for nucleosome binding and ubiquitin‐dependent stimulation. Through site‐directed photo‐crosslinking, we identified specific IDR residues mediating interactions with nucleosomal surfaces. Furthermore, using an isoUb‐based synthetic approach, we generated H3K9NleK14Ub nucleosomes and determined cryo‐EM structures of Clr4–nucleosome complexes, unveiling multivalent nucleosome recognition by the IDR via four distinct interfaces: the H2A–H2B acidic patch, the H2A/H2B basic groove, the H2B and H3 elbow regions. Methyltransferase activity assays confirmed that mutations disrupting these interfaces impair Clr4 activity. Our study provides mechanistic insights into the ubiquitin‐dependent activation mechanism of Clr4, highlighting the power of chemical biology in deciphering epigenetic regulation.
Article Details
Authors (6)
Maoshen Sun
Howard Hughes Medical Institute, Department of Cell Biology
Yunxiang Du
Zhengqing Li
Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Department of Chemistry, Tsinghua University Beijing China
Akejiang Aderjiang
School of Pharmaceutical Sciences, Shanghai Key Laboratory for Antibody‐Drug Conjugates with Innovative Target, Center for Chemical Glycobiology‐Zhangjiang Institute for Advanced Study, Shanghai Frontiers Science Center of Drug Target Identification and Delivery Shanghai Jiao Tong University Shanghai China
Meixuan Xin
Huasong Ai
School of Pharmaceutical Sciences, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, Center for Chemical Glycobiology-Zhangjiang Institute for Advanced Study, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Research Center for Chemical Biology of Post-translational Modifications